Wednesday, 18 March 2015
Vaping versus Varenicline!
The U.S. Food and Drug Administration (FDA) is warning that the prescription smoking cessation medicine Chantix (varenicline) / Champix in Canada can change the way people react to alcohol. In addition, rare accounts of seizures in patients treated with Chantix have been reported. Various psychiatric symptoms have also been reported. They have approved changes to the Chantix label to warn about these risks. Until patients know how Chantix affects their ability to tolerate alcohol, they should decrease the amount of alcohol they drink. Patients who have a seizure while taking Chantix should stop the medicine and seek medical attention immediately.
Millions of Americans have serious health problems caused by smoking, which can be reduced by quitting. Chantix is a prescription medicine that is FDA-approved to help adults quit smoking. In clinical trials, Chantix increased the likelihood of quitting smoking and “staying quit” for as long as 1 year compared to treatment with a placebo, an inactive treatment.
It is somewhat ironic that Chantix/ Champix is widely accepted despite its recognized dangers, while vaping, which seems to be relatively innocuous so far, is looked upon disapprovingly by many.
Could it be that the witch hunt is so much fun that anything that even looks like a cigarette should be hunted down even if it helps people to quit smoking?
Tell me what you think!